NeuroMetrix, Inc. (Nasdaq: NURO) reported purchases during August 2015
of the company’s common stock by its Chief Executive Officer, Dr. Shai
N. Gozani and Chief Financial Officer, Thomas T. Higgins. Details of
these transactions may be found on the U.S. Securities and Exchange
Commission’s EDGAR website at the following links:
Form
4 SNG 08 11 15
Form
4 TTH 08 20 15
Form
4 TTH 08 28 15
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150917006108/en/
Copyright Business Wire 2015